Longeveron (LGVN)
0.61
-0.02 (3.17%)
Upcoming Events
Latest Headlines
Longeveron adds Dr. Deborah Ascheim to its board of directors
July 23, 2026 9:15 AM - StreetInsider
Deborah D. Ascheim, M.D. Elected to Longeveron Board of Directors
July 23, 2026 9:15 AM - Globe NewsWire
Form 3 Longeveron Inc. For: Jul 13 Filed by: Washburn Marie
July 21, 2026 6:00 PM - SEC Filing
Form 3 Longeveron Inc. For: Jul 02 Filed by: Desai Arjun JJ
July 14, 2026 6:00 PM - SEC Filing
Form 8-K Longeveron Inc. For: Jul 08
July 14, 2026 5:20 PM - SEC Filing
Form 3 Longeveron Inc. For: Jul 01 Filed by: Ascheim Deborah
July 13, 2026 6:00 PM - SEC Filing
Form 3 Longeveron Inc. For: Jul 01 Filed by: Cann Leah Rush
July 13, 2026 6:00 PM - SEC Filing
Longeveron shares Phase 2a laromestrocel data at AAIC 2026
July 13, 2026 7:06 AM - StreetInsider
Longeveron Announces Presentation of Clinical Data at the 2026 Alzheimer’s Association International Conference (AAIC) that Indicate Its Cellular Therapy Laromestrocel Reduced Neuroinflammation in P
July 13, 2026 7:05 AM - Globe NewsWire
Form S-8 Longeveron Inc.
July 10, 2026 4:47 PM - SEC Filing
Form 4 Longeveron Inc. For: Jul 06 Filed by: Hare Joshua
July 8, 2026 6:00 PM - SEC Filing
Form 8-K Longeveron Inc. For: Jul 08
July 8, 2026 4:06 PM - SEC Filing
Form 4 Longeveron Inc. For: Jul 01 Filed by: Willard Stephen H
July 6, 2026 8:55 PM - SEC Filing
Form 4 Longeveron Inc. For: Jul 01 Filed by: Locklear Lisa
July 6, 2026 8:55 PM - SEC Filing
Form 4 Longeveron Inc. For: Jul 01 Filed by: Agafonova Nataliya
July 6, 2026 8:55 PM - SEC Filing
Form 4 Longeveron Inc. For: Jul 01 Filed by: Blass Devin
July 6, 2026 8:55 PM - SEC Filing
Form 4 Longeveron Inc. For: Jul 01 Filed by: Lehr Paul T
July 6, 2026 8:55 PM - SEC Filing
Form 8-K Longeveron Inc. For: Jun 30
July 6, 2026 4:31 PM - SEC Filing
Longeveron names Marie Washburn as CFO, effective July 13
July 6, 2026 4:05 PM - StreetInsider
Longeveron® Appoints Marie Washburn as Chief Financial Officer
July 6, 2026 4:05 PM - Globe NewsWire
Longeveron stem cell therapy data to be presented at 2026 AAIC
June 18, 2026 9:20 AM - StreetInsider
New Phase 2a Clinical Data Analysis of Stem Cell Therapy Laromestrocel in Mild Alzheimer’s Disease Accepted for Poster Presentation at the 2026 Alzheimer’s Association International Conference (AA
June 18, 2026 9:20 AM - Globe NewsWire
Longeveron receives SME status from European Medicines Agency
June 9, 2026 9:20 AM - StreetInsider
Longeveron Granted Small or Medium-sized Enterprise (SME) Status by the European Medicines Agency (EMA)
June 9, 2026 9:20 AM - Globe NewsWire
Longeveron CFO Lisa Locklear to step down in July
June 5, 2026 4:04 PM - StreetInsider
Form 8-K Longeveron Inc. For: Jun 01
June 5, 2026 4:01 PM - SEC Filing
Longeveron to Present at BIO International Convention 2026
June 4, 2026 9:15 AM - Globe NewsWire
Form ARS Longeveron Inc. For: Dec 31
May 20, 2026 4:13 PM - SEC Filing
Form DEFA14A Longeveron Inc.
May 20, 2026 4:12 PM - SEC Filing
Form DEF 14A Longeveron Inc. For: Jul 01
May 20, 2026 4:11 PM - SEC Filing
Longeveron CEO outlines strategy focused on partnerships and 2026 milestones
May 20, 2026 4:06 PM - StreetInsider
Longeveron Issues Letter to Stockholders Highlighting Corporate Strategy, Strategic Partnering Approach and 2026 Key Priorities
May 20, 2026 4:05 PM - Globe NewsWire
Form SCHEDULE 13G Longeveron Inc. Filed by: JANUS HENDERSON GROUP PLC
May 15, 2026 11:43 AM - SEC Filing
Longeveron (LGVN) Misses Q1 EPS by 19c
May 13, 2026 4:41 PM - StreetInsider
Form 8-K Longeveron Inc. For: May 13
May 13, 2026 4:15 PM - SEC Filing
Longeveron Announces 2026 First Quarter Financial Results and Provides Business Update
May 13, 2026 4:05 PM - Globe NewsWire
Form 10-Q Longeveron Inc. For: Mar 31
May 13, 2026 4:02 PM - SEC Filing
Longeveron receives committee approval to complete stem cell trial
May 11, 2026 9:10 AM - StreetInsider
Longeveron Announces Independent Data Monitoring Committee Positive Review and Recommendation to Complete Phase 2b Stem Cell Therapy Clinical Trial in Hypoplastic Left Heart Syndrome (HLHS)
May 11, 2026 9:10 AM - Globe NewsWire
Maxim Group Downgrades Longeveron (LGVN) to Hold
May 11, 2026 7:44 AM - StreetInsider
Form 8-K Longeveron Inc. For: May 08
May 8, 2026 4:20 PM - SEC Filing
Longeveron meets with FDA on heart syndrome drug trial
May 8, 2026 4:05 PM - StreetInsider
Longeveron Announces Constructive Type C Meeting with U.S. FDA Ahead of Data Readout for ELPIS II Phase 2b Clinical Trial Evaluating Treatment for Hypoplastic Left Heart Syndrome (HLHS)
May 8, 2026 4:05 PM - Globe NewsWire
Form 4 Longeveron Inc. For: May 01 Filed by: Blass Devin
May 5, 2026 6:00 PM - SEC Filing
Form 4 Longeveron Inc. For: May 01 Filed by: Willard Stephen H
May 5, 2026 6:00 PM - SEC Filing
Form 4 Longeveron Inc. For: May 01 Filed by: Agafonova Nataliya
May 5, 2026 6:00 PM - SEC Filing
Form 4 Longeveron Inc. For: May 01 Filed by: Lehr Paul T
May 5, 2026 6:00 PM - SEC Filing
Form 4 Longeveron Inc. For: May 01 Filed by: Locklear Lisa
May 5, 2026 6:00 PM - SEC Filing
Form PRE 14A Longeveron Inc. For: May 05
May 5, 2026 5:43 PM - SEC Filing
Longeveron to Report 2026 First Quarter Financial Results and Host Conference Call on May 13, 2026
May 5, 2026 4:15 PM - Globe NewsWire
Longeveron (LGVN) PT Lowered to $8 at H.C. Wainwright
May 4, 2026 7:28 AM - StreetInsider
Full Article List
